Nirsevimab Reduced Hospitalizations for Infants With RSV
(MedPage Today) -- The monoclonal antibody nirsevimab (Beyfortus) reduced hospitalizations among infants with respiratory syncytial virus (RSV)-associated lower respiratory tract infection, the randomized, pragmatic HARMONIE trial showed.
In over...
Source: MedPage Today Infectious Disease - Category: Infectious Diseases Source Type: news
More News: Infectious Diseases | Respiratory Medicine